Literature DB >> 11733185

Rate of endothelial expansion is controlled by cell:cell adhesion.

P Anne Underwood1, Penny A Bean, Jennifer R Gamble.   

Abstract

Procedures used to alleviate blood vessel occlusion result in varying degrees of damage to the vascular wall and endothelial denudation. The presence of intact, functioning endothelium is thought to be important in controlling smooth muscle cell growth, and limiting the intimal thickening which results from damage to the vessel wall. Recovery of the endothelium is commonly slow and incomplete, due in part to endothelial lateral cell:cell adhesion, which limits cell migration and proliferation. We have investigated the effect of fibroblast growth factor 2 and vascular/endothelial growth factor on the relationship between the temporal distribution of the junctional adhesion proteins, platelet/endothelial cell adhesion molecule, vascular/endothelial cadherin and plakoglobin, and cellular migration and proliferation in an in vitro model of endothelial expansion. We found that whereas cell:cell junctions were initially disturbed to similar extents by single applications of the growth factors, outward cell migration and proliferation rates were inversely correlated with the speed at which cell:cell junctions were re-established. This occurred very rapidly with vascular/endothelial growth factor treatment and more slowly with fibroblast growth factor-2, resulting in more extensive outward migration and proliferation in response to the latter. Platelet/endothelial cell adhesion molecule and vascular/endothelial cadherin appeared to be associated with cell:cell junctional control of migration and proliferation, while plakoglobin did not contribute. It was concluded that the rate of endothelial expansion in response to growth factors, is limited by the rate of re-association of junctional complexes following initial disruption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11733185     DOI: 10.1016/s1357-2725(01)00100-5

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 2.  The influence of biomaterials on endothelial cell thrombogenicity.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2007-02-09       Impact factor: 12.479

3.  Implanted neonatal human dermal fibroblasts influence the recruitment of endothelial cells in mice.

Authors:  Susana G Guerreiro; Christoph Brochhausen; Rita Negrão; Mário A Barbosa; Ronald E Unger; C James Kirkpatrick; Raquel Soares; Pedro L Granja
Journal:  Biomatter       Date:  2012 Jan-Mar

4.  Engineering amount of cell-cell contact demonstrates biphasic proliferative regulation through RhoA and the actin cytoskeleton.

Authors:  Darren S Gray; Wendy F Liu; Colette J Shen; Kiran Bhadriraju; Celeste M Nelson; Christopher S Chen
Journal:  Exp Cell Res       Date:  2008-07-09       Impact factor: 3.905

5.  Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC.

Authors:  Marc S Ballas; Abraham Chachoua
Journal:  Onco Targets Ther       Date:  2011-05-30       Impact factor: 4.147

6.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

7.  bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice.

Authors:  Laura Parma; Hendrika A B Peters; Thijs J Sluiter; Karin H Simons; Paolo Lazzari; Margreet R de Vries; Paul H A Quax
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.